{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:21:22Z","timestamp":1792009282962,"version":"4.4.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Aetiological diagnosis and targeted antibiotic therapy are essential to improve the prognosis of patients with infective endocarditis. Molecular tests on blood have been reported to be effective in identifying the causative organism and are recommended when blood cultures are negative. The role of molecular tests on the surgically excised valve is still unclear and needs further investigation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In this prospective, observational, single center study, we enrolled 100 consecutive patients with native or prosthetic valve endocarditis who underwent cardiac surgery between April 2020 and June 2023. Results of preoperative blood cultures, valve culture, 16s ribosomal RNA and histopathologic analysis of surgical samples were collected in a dedicated database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age of the study population was 60\u2009\u00b1\u200912.5 years, with a majority of men (73%). Previous cardiac surgery was reported in 31% of patients. Blood culture, valve culture, and 16srRNA were positive in 83%, 47%, and 76% of cases, respectively. The sensitivity of both valve culture and 16srRNA decreased significantly with prolonged preoperative antibiotic therapy. Of note, 16srRNA was the only positive result in 7% of cases, allowing aetiological diagnosis. In 33% of patients, the valve culture test was negative while the molecular test was positive. In these cases, histopathological analysis showed acute inflammation in most cases. In 10%, the molecular test helped in resolving discrepancies between the results of blood and valve cultures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The molecular test showed significantly higher diagnostic sensitivity than valve culture and maintained this efficacy even after 28 days of preoperative antibiotic therapy. In addition to identifying the pathogen in 7% of cases with negative culture results, the molecular test demonstrated utility in other crucial situations. When valve cultures were negative, combining molecular testing and histopathological analysis they allowed the identification of patients who could benefit from prolonged antibiotic therapy. In addition, molecular testing guided the choice of antibiotic treatment when there was a discrepancy between blood culture and valve culture results. Based on these findings, molecular testing should be considered in all patients with infective endocarditis undergoing cardiac surgery.\n<\/jats:p><jats:p><jats:bold>Clinical Trial Registration<\/jats:bold>: <jats:uri>ClinicalTrials.gov<\/jats:uri>, identifier (NCT05791357).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1504197","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:11:57Z","timestamp":1734523917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery"],"prefix":"10.3389","volume":"11","author":[{"given":"Natalia","family":"Pavone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cammertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giovannenze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"D\u2019Inzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessica","family":"Cutrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Del Zanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Massetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/003655400750044908","article-title":"Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium","volume":"32","author":"Alestig","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"IV2","DOI":"10.1007\/s003920070058","article-title":"Endocarditis: epidemiology, diagnosis and treatment","volume":"89","author":"Horstkotte","year":"2000","journal-title":"Z Kardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1086\/653675","article-title":"Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases","volume":"51","author":"Fournier","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1128\/JCM.02173-0","article-title":"Group for the management of infective endocarditis of the gregorio mara\u00f1\u00f3n hospital. Heart valves should not be routinely cultured","volume":"46","author":"Mu\u00f1oz","year":"2008","journal-title":"J Clin Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1469-0691.2008.02094","article-title":"Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm","volume":"14","author":"Gouriet","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1128\/JCM.43.10.5238-5242.2005","article-title":"Contribution of systematic serological testing in diagnosis of infective endocarditis","volume":"43","author":"Raoult","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(15)00067-7","article-title":"Infective endocarditis","volume":"387","author":"Cahill","year":"2016","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10096-018-03451-5","article-title":"Impact of pre-operative antimicrobial treatment on microbiological findings from endocardial specimens in infective endocarditis","volume":"38","author":"Halavaara","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/CIRCULATIONAHA.117.02878311","article-title":"Prosthetic valve endocarditis after surgical aortic valve replacement","volume":"136","author":"Glaser","year":"2017","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00392-020-01629-6","article-title":"Case report: takotsubo syndrome in infectious endocarditis","volume":"109","author":"Rattka","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00392-020-01678-x1","article-title":"The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology","volume":"110","author":"Armstrong","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1484","DOI":"10.1093\/cid\/ciac452","article-title":"Molecular analysis with 16S rRNA PCR\/sanger sequencing and molecular antibiogram performed on DNA extracted from valve improve diagnosis and targeted therapy of infective endocarditis: a prospective study","volume":"76","author":"Mularoni","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/jcm.35.11.2733-2739.1997","article-title":"Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing","volume":"35","author":"Goldenberger","year":"1997","journal-title":"J Clin Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/eurheartj\/ehp600","article-title":"23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis","volume":"31","author":"Vollmer","year":"2010","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00005792-200109000-00003","article-title":"Infective endocarditis -a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality","volume":"80","author":"Bouza","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/hrt.2005.067256","article-title":"The changing face of infective endocarditis","volume":"92","author":"Prendergast","year":"2006","journal-title":"Heart"},{"key":"B18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MD.0b013e31811f44ec","article-title":"Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue","volume":"86","author":"Mar\u00edn","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/s0003-4975(99)01354-5","article-title":"Evaluation of the practice of routine culturing of native valves during valve replacement surgery","volume":"69","author":"Campbell","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/clinids\/24.5.884","article-title":"Microbiological cultures of heart valves and valve tags are not valuable for patients without infective endocarditis who are undergoing valve replacement","volume":"24","author":"Giladi","year":"1997","journal-title":"Clin Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2017.06.008","article-title":"Added diagnostic value and impact on antimicrobial therapy of 16S rRNA PCR and amplicon sequencing on resected heart valves in infective endocarditis: a prospective cohort study","volume":"23","author":"Peeters","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.athoracsur.2014.07.028","article-title":"Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients","volume":"99","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/07853890600622119","article-title":"Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital","volume":"38","author":"Kotilainen","year":"2006","journal-title":"Ann Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/JCM.43.1.163-167.2005","article-title":"PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis","volume":"43","author":"Rovery","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3343\/alm.2017.37.6.505","article-title":"Utility of a direct 16S rDNA PCR and sequencing for etiological diagnosis of infective endocarditis","volume":"37","author":"Kim","year":"2017","journal-title":"Ann Lab Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12879-021-05892-4","article-title":"Revised version (INFD-D-20-00242): impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective study","volume":"21","author":"Ursenbach","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/cid\/ciab167","article-title":"Diagnostic value of 16S ribosomal RNA gene polymerase chain reaction\/sanger sequencing in clinical practice","volume":"73","author":"Fida","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1504197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:12:00Z","timestamp":1734523920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1504197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2024.1504197"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1504197","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"article-number":"1504197"}}